Molecular mechanism of levosimendan action: an update.
Rosevear
Paul R
PR
Finley
Natosha
N
D000595:Amino Acid Sequence; D001665:Binding Sites; D002118:Calcium / Q000378:metabolism; D002316:Cardiotonic Agents / Q000494:pharmacology*; D004347:Drug Interactions; D006801:Humans; D006835:Hydrazones / Q000494:pharmacology*; D009200:Myocardial Contraction; D019906:Nuclear Magnetic Resonance, Biomolecular; D010446:Peptide Fragments / Q000737:chemistry / Q000378:metabolism*; D010766:Phosphorylation; D011485:Protein Binding; D011487:Protein Conformation; D017433:Protein Structure, Secondary; D017434:Protein Structure, Tertiary; D011724:Pyridazines / Q000494:pharmacology*; D000077464:Simendan; D013329:Structure-Activity Relationship; D019209:Troponin C / Q000737:chemistry* / Q000235:genetics / Q000378:metabolism; D019210:Troponin I / Q000737:chemistry* / Q000378:metabolism
D002316:Cardiotonic Agents; D006835:Hydrazones; D010446:Peptide Fragments; D011724:Pyridazines; D019209:Troponin C; D019210:Troponin I; D000077464:Simendan; D002118:Calcium